Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Juniper is a deep tech venture capital firm founded to invest in biotechnology and engineered biology. Established to support visionary founders, Juniper aims to transform life sciences and unlock new markets and industries. The firm partners with entrepreneurs to advance innovations across manufacturing, mining, food, agriculture, and conservation.
Currently, Juniper manages a portfolio of 8 companies, focusing on pre-seed, seed, and seed-plus investment stages. The firm operates with a team of three key individuals, including founding partners Jennifer Kan, PhD, and Michael Luciani, alongside Chief of Staff Mackenzie Scurka. Their collective expertise drives Juniper's mission to capitalize on breakthroughs in biology, engineering, and computation.
Juniper's headquarters are not explicitly stated, but they actively promote their mission through their website, emphasizing their commitment to fostering innovation in life sciences and engineered biology.
Juniper invests primarily in platforms for catalyst discovery, biomanufacturing, and various applications of engineered biology. Their investment strategy targets sectors such as biotechnology, healthcare, food-agtech, and mining. The firm emphasizes supporting technical founders at the earliest stages of company formation, particularly those creating new categories and upgrading production methods.
Investment checks typically occur at the pre-seed, seed, and seed-plus stages, allowing Juniper to engage with startups as they develop their foundational technologies. The firm seeks to capitalize on breakthroughs in biology, engineering, and computation, aiming to partner with entrepreneurs who are pioneering advancements in these fields.
Juniper's portfolio includes 8 notable companies that exemplify their focus on biotechnology and engineered biology:
These companies reflect Juniper's commitment to supporting innovative solutions in life sciences and engineered biology.
Jennifer Kan, PhD: Founding Partner. Jennifer has a strong background in biotechnology and has led numerous investments in the sector. Her expertise lies in identifying transformative technologies and supporting technical founders.
Michael Luciani: Founding Partner. Michael brings extensive experience in venture capital and has a track record of successful investments in early-stage biotech companies.
Mackenzie Scurka: Chief of Staff. Mackenzie plays a crucial role in operations and supports the firm's strategic initiatives, ensuring effective collaboration within the team and with portfolio companies.
Juniper runs a program called Juniper, which focuses on supporting early-stage biotechnology startups. This program aims to provide resources, mentorship, and networking opportunities for founders in the deep tech space.
Eligibility criteria and application details for the Juniper program are not explicitly stated, but interested founders can inquire through the firm's website.
As of October 2023, Juniper has been actively promoting its mission to support advancements in life sciences and engineered biology through its website content. They continue to highlight their commitment to partnering with entrepreneurs and fostering innovation across various industries.
Recent updates include the addition of new companies to their portfolio, reflecting their ongoing investment activity in the biotechnology sector. Specific details on these investments have not been disclosed.
What are Juniper's investment criteria?
Juniper focuses on early-stage investments in biotechnology and engineered biology, particularly in sectors like food, agriculture, healthcare, and mining. They seek technical founders who are creating new categories and upgrading production methods.
How can I pitch to Juniper?
Founders can submit their pitches through the Juniper website at junipervc.com. It is advisable to include detailed information about the technology, market potential, and team in the pitch deck.
What makes Juniper different from other VCs?
Juniper specializes in deep tech investments, focusing on transformative biotechnology and engineered biology. Their emphasis on supporting technical founders at the earliest stages sets them apart from many other venture capital firms.
What is Juniper's geographic scope?
While specific geographic preferences are not detailed, Juniper's focus on biotechnology suggests a potential interest in regions with strong life sciences ecosystems.
What is Juniper's follow-on investment behavior?
Juniper typically engages with companies at the pre-seed and seed stages, indicating a likelihood of follow-on investments as companies progress and meet milestones.
What is the typical check size for Juniper?
Juniper invests at the pre-seed, seed, and seed-plus stages, but specific check sizes are not disclosed. Founders should prepare for varying amounts based on the stage and potential of their startups.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.